NCT04338568

Brief Summary

COVID-19 is a rapidly spreading and very contagious disease caused by a novel coronavirus that can lead to respiratory insufficiency. In many patients, the chest radiograph at first presentation be normal, and early low-dose CT-scan is advocated to diagnose viral pneumonia. Lung ultrasound (LUS) has similar diagnostic properties as CT for diagnosing pneumonia. However, it has the advantage that it can be performed at point-of-care, minimizing the need to transfer the patient, reducing the number of health care personnel and equipment that come in contact with the patient and thus potentially decrease the risk of spreading the infection. This study has the objective to examine the accuracy of lung ultrasound in patients with proven COVID-19 pneumonia.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 4, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

April 8, 2020

Completed
8 days until next milestone

Study Start

First participant enrolled

April 16, 2020

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2020

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2020

Completed
Last Updated

August 17, 2020

Status Verified

August 1, 2020

Enrollment Period

8 months

First QC Date

April 4, 2020

Last Update Submit

August 14, 2020

Conditions

Keywords

accuracyinter-observer variability

Outcome Measures

Primary Outcomes (2)

  • Accuracy of the diagnosis of interstitial syndrome by lung ultrasound

    The diagnostic accuracy of lung ultrasound is more than 90% compared to low-dose CT or chest X-ray for the detection of viral pneumonia in patients with COVID-19 infection.

    within 2 weeks after first subject included

  • Inter-observer variability

    The interobserver variability by lung ultrasound between the 2 observers for the diagnosis of interstitial syndrome by lung ultrasound is \> 0.6 measured by the Kappa score

    within 2 weeks after first subject included

Study Arms (2)

LUS observer 1

ACTIVE COMPARATOR

The subject will undergo a Lung Ultrasound by observer nr 1

Diagnostic Test: Lung ultrasound

LUS observer 2

ACTIVE COMPARATOR

The subject will undergo a Lung Ultrasound by observer nr 2

Diagnostic Test: Lung ultrasound

Interventions

Lung ultrasoundDIAGNOSTIC_TEST

The lung ultrasound examination consists of two-sided scanning of the anterior and lateral chest wall and is performed with patients in supine or near-to-supine position.

LUS observer 1LUS observer 2

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years or older
  • Oxygen saturation of \< 93% in ambient air
  • Signed written informed consent

You may not qualify if:

  • Contra-indication for lung ultrasound
  • Other causes of hypoxia or of pulmonary infiltrates on CT thorax or chest X-ray

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ziekenhuis Oost Limburg

Genk, Limburg, 3600, Belgium

RECRUITING

Related Publications (3)

  • Ramirez P, Torres A. Should ultrasound be included in the initial assessment of respiratory patients? Lancet Respir Med. 2014 Aug;2(8):599-600. doi: 10.1016/S2213-2600(14)70142-0. Epub 2014 Jul 3. No abstract available.

    PMID: 24998675BACKGROUND
  • Pisani L, Vercesi V, van Tongeren PSI, Lagrand WK, Leopold SJ, Huson MAM, Henwood PC, Walden A, Smit MR, Riviello ED, Pelosi P, Dondorp AM, Schultz MJ; Lung Ultrasound Consortium. The diagnostic accuracy for ARDS of global versus regional lung ultrasound scores - a post hoc analysis of an observational study in invasively ventilated ICU patients. Intensive Care Med Exp. 2019 Jul 25;7(Suppl 1):44. doi: 10.1186/s40635-019-0241-6.

  • Li K, Fang Y, Li W, Pan C, Qin P, Zhong Y, Liu X, Huang M, Liao Y, Li S. CT image visual quantitative evaluation and clinical classification of coronavirus disease (COVID-19). Eur Radiol. 2020 Aug;30(8):4407-4416. doi: 10.1007/s00330-020-06817-6. Epub 2020 Mar 25.

Study Officials

  • Michiel Thomeer, MD,PhD

    Ziekenhuis Oost-Limburg

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Michiel J Thomeer, MD,PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Model Details: Patients with the diagnosis of COVID-19 pneumonia will undergo a lung ultrasound, by two observers each. The findings will be compared with findings on chest x-ray and/or CT thorax. Accuracy and inter-observer variability will be calculated.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof.Dr.Michiel Thomeer

Study Record Dates

First Submitted

April 4, 2020

First Posted

April 8, 2020

Study Start

April 16, 2020

Primary Completion

November 30, 2020

Study Completion

December 30, 2020

Last Updated

August 17, 2020

Record last verified: 2020-08

Data Sharing

IPD Sharing
Will not share

no plan

Available IPD Datasets

Clinical Study Report Access

Locations